Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease. [electronic resource]
Producer: 20191025Description: 621-639 p. digitalISSN:- 1432-0533
- Amphetamine -- pharmacology
- Animals
- Central Nervous System Stimulants -- pharmacology
- Dependovirus -- genetics
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Neostriatum -- pathology
- Nerve Degeneration -- genetics
- Neurons -- pathology
- Parkinson Disease -- genetics
- Stereotyped Behavior -- drug effects
- Substantia Nigra -- pathology
- Synapses -- pathology
- Synapsins -- deficiency
- Vesicle-Associated Membrane Protein 2 -- metabolism
- alpha-Synuclein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.